GMAB
GENMAB A/S
Next earnings Aug 6, 2026 · consensus $3.48 EPS, $1.11B rev
$28.52
▲ +9.59%$28.52▲ +39.10%
over 1Y
L $20.30H $35.34
Today+9.6%
1W+9.1%
1M+19.6%
3M+3.7%
YTD-10.4%
1Y+39.1%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 25 analysts
Buy
Mixed signals in the latest filings.
GENMAB A/S shows limited reported revenue.
On these fundamentals, GMAB screens as SELL on the SEC figures.
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 10:19 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Key statistics
Valuation
Enterprise value$17.5B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗6-KPeriod ending 2026-06-292026-06-29open ↗6-KPeriod ending 2026-06-172026-06-17open ↗6-KPeriod ending 2026-06-162026-06-16open ↗6-KPeriod ending 2026-06-152026-06-15open ↗6-KPeriod ending 2026-06-152026-06-15open ↗6-KPeriod ending 2026-06-112026-06-11open ↗6-KPeriod ending 2026-05-292026-05-29open ↗SCHEDULE 13G/AFiling2026-05-15open ↗6-KPeriod ending 2026-05-132026-05-13open ↗6-KPeriod ending 2026-05-122026-05-12open ↗6-KPeriod ending 2026-05-082026-05-08open ↗6-KPeriod ending 2026-05-072026-05-07open ↗
Frequently asked
- Is GENMAB A/S (GMAB) a buy?
- GMAB currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
- What is GENMAB A/S's quality score?
- GMAB scores 67.35193575791901/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001434265, latest 6-K filed 2026-06-29) · EODHD · as of 7/4/2026, 2:19:22 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.